Traditional Chinese medicine for treating chronic lymphatic thyroiditis

Abstract

The invention discloses a traditional Chinese medicine for treating chronic lymphatic thyroiditis. The traditional Chinese medicine is prepared from 10-20 g of Chinese thorowax, 15-20 g of angelica, 13-18 g of white paeony root, 15-20 g of nutgrass galingale rhizome, 10-20 g of prunella, 10-20 g of thunbery fritillary bulb, 10-15 g of seed cowherb, 15-20 g of marine algae, 13-16 g of laminaria, and 10-20 g of dried orange peel. The traditional Chinese medicine has a good curative effect, is well-targeted in practice, and has small side effects. Clinical observation of large samples and animal experiment researches at the prior stage prove that the traditional Chinese medicine compound has the multi-target effects of reducing the antibody level of thyroid of patients with chronic lymphatic thyroiditis as well as of blood serum of animal models, reducing lymphocyte soakage of thyroid tissues, and inhibiting apoptosis of thyroid cells, and has definite curative effects. The traditional Chinese medicine achieves better effects of treating chronic lymphatic thyroiditis at subclinical stage and clinical stage, has a good market application potential and a good prospect, and is bound to bring good economic and social benefits.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine capable of effectively treating chronic lymphocytic thyroiditis. Background technique [0002] At present, the disease is in the subclinical stage (TSH elevation < 10U / ml), Western medicine does not give drug treatment, and adopts follow-up observation; when clinical hypothyroidism occurs, Western medicine mainly adopts hormone therapy, immunotherapy, etc., with limited curative effect and side effects big. Pharmacological studies of traditional Chinese medicine have shown that many traditional Chinese medicines have the function of regulating the body's immune function, regulating and restoring the body's immune function, inhibiting the body's humoral and cellular immune responses, and inhibiting the generation of T lymphocyte receptors. Therefore, in the subclinical stage of this disease It has unique advantages and good application prospects ...

AI Technical Summary

Problems solved by technology

[0002]At present, the disease is in the subclinical stage (TSH elevation <10U / ml), Western medicine does not give drug treatment, and follow-up observation is adopted; clinical hypothyroidism occurs, Western medicine mainly adopts hormone therapy, immunotherapy, etc., with limited curative effect and relatively large side effects

Images